Trial
NCT05562973
Safety and Tolerability of Psilocybin in Post-Traumatic Stress Disorder
Phase IWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
Johns Hopkins University
Collaborators
—
Condition
Post-Traumatic Stress Disorder
Intervention
Psilocybin
Why stopped
The principal investigator will be at a new institution.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2024-01-05